SCHEMBL25875975

SCHEMBL25875975

COC(=O)C1(OC)CC=C(c2nc(C)c3cnn(CC(F)F)c3n2)CC1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25875973 0.91 — —
SCHEMBL25876241 0.89 MEN1 (0.31) —
SCHEMBL25875947 0.89 MEN1 (0.37) —
SCHEMBL25876305 0.88 PIK3CA (0.39) —
SCHEMBL25876281 0.87 PDE1A (0.34) —
SCHEMBL25876085 0.86 MERTK (0.33) —
SCHEMBL25875751 0.84 TP53 (0.32) —
SCHEMBL25875899 0.83 KLKB1 (0.33) —
SCHEMBL25876137 0.81 PIK3CA (0.35) —
SCHEMBL25876054 0.80 PDE9A (0.31) —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230234954-A1 COMPOUND USED AS RET KINASE INHIBITOR AND APPLICATION THEREOF TYK MEDICINES, INC. (CN) 2023-07-27 — — US disclosed
Send feedback